Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if therapeutic modification of insulin resistance or oxidative stress leads to improvement in serum or histologic indicators of liver injury or quality of lif...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT07265544 · Liver Neoplasm, HBV Infection, and more
NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more
NCT02815891 · Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis
NCT07237750 · Overweight and/or Obesity, Metabolic Syndrome, and more
NCT07466485 · Alcoholic Fatty Liver Disease
University of California, San Diego
San Diego, California
University of California, San Francisco
San Francisco, California
Children's National Medical Center
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions